deoxyglucose has been researched along with 2019 Novel Coronavirus Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, AN; Chandna, S; Chinnadurai, V; Harshan, KH; Kumar, A; Kumari, N; Rai, Y; Vedagiri, D | 1 |
| Bhansali, MP; Bhansali, PR; Borkar, MR; Chaturbhuj, GU; Muntean, BS; Viola, RE; Wijayasinghe, YS | 1 |
| Emmett, MR; Fokt, I; Manning, JT; Matejin, S; Paessler, S; Pająk, B; Priebe, W; Zieliński, R | 1 |
| Han, Z; Huang, W; Huang, X; Kane, MA; Lee, H; Lee, JG; van de Leemput, J; Wang, G; Yang, P; Zhu, JY | 1 |
| Adhikary, A; Dwarakanath, BS; Papineni, RVL; Verma, A; Woloschak, G | 1 |
| Lampidis, TJ; Mesri, EA | 1 |
2 review(s) available for deoxyglucose and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses.
Topics: Antiviral Agents; COVID-19; Deoxyglucose; Glucose; Glycolysis; Humans; Mannose; SARS-CoV-2; Zika Virus; Zika Virus Infection | 2022 |
2-Deoxy-d-glucose exploits increased glucose metabolism in cancer and viral-infected cells: Relevance to its use in India against SARS-CoV-2.
Topics: COVID-19; Deoxyglucose; Glucose; Humans; India; Neoplasms; SARS-CoV-2 | 2021 |
4 other study(ies) available for deoxyglucose and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions.
Topics: Adenosine Triphosphate; Animals; Antiviral Agents; Cell Proliferation; Cell Survival; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Deoxyglucose; Glucose; Glycolysis; Glycosylation; Host-Pathogen Interactions; Mannose; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virion; Virus Replication | 2022 |
A Comprehensive Biological and Synthetic Perspective on 2-Deoxy-d-Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials.
Topics: Adenosine Triphosphate; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Deoxyglucose; Epilepsy; Glycolysis; Humans; Isotope Labeling; Mitochondria; Neoplasms; Positron-Emission Tomography; SARS-CoV-2; Structure-Activity Relationship; Virus Replication | 2022 |
SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.
Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Basic Helix-Loop-Helix Transcription Factors; COVID-19; Deoxyglucose; Drosophila; Drosophila Proteins; Glycolysis; Heart Failure; Mice; Myocytes, Cardiac; Polycomb Repressive Complex 1; Reactive Oxygen Species; SARS-CoV-2 | 2022 |
A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
Topics: Betacoronavirus; Combined Modality Therapy; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Deoxyglucose; Humans; Pandemics; Pneumonia, Viral; Radiotherapy Dosage; SARS-CoV-2 | 2020 |